/PRNewswire/ The "COVID-19 Testing: Global Strategic Business Report" report has been added to ResearchAndMarkets.com s offering. Global COVID-19 Testing.
COVID Testing Kit Market Overview According to a Comprehensive Research Report by Market Research Future (MRFR), “COVID Testing Kit Market Information by Type,
Chester County sues Malvern company Advaite over coronavirus antibody tests inquirer.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inquirer.com Daily Mail and Mail on Sunday newspapers.
Share this article
Share this article
MALVERN, Pa., Jan. 12, 2021 /PRNewswire/ The U.S. Food and Drug Administration has granted Emergency Use Authorization (EUA) to one of the first U.S.-manufactured serology tests designed by ADVAITE Inc., an innovative biotech company developing novel point-of-care assays to help with combatting COVID-19.
The federal government s EUA for ADVAITE s rapid response IgG antibody test will strengthen America s public health protections against epidemiological threats by facilitating access to cutting-edge medical countermeasures, such as ADVAITE S RapCov™ Rapid COVID-19 Test. ADVAITE is one of only a handful of US manufacturers to receive EUA for a point-of-care serology test.